Alkermes (NASDAQ: ALKS) reported Q4 EPS of $0.22, $0.23 worse than the analyst estimate of $0.45. Revenue for the quarter came in at $377.5 million versus the consensus estimate of $362.91 million.

For earnings history and earnings-related data on Alkermes (ALKS) click here.